Get startedLog in
    Picture of Psomagen logo

    950200 — Psomagen Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Psomagen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-19.8-18.3-6.17-0.807-3.36
    Depreciation
    Amortisation
    Non-Cash Items169.950.2860.2060.611
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-1.010.693-1.74-2.660.898
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-1.5-4.2-4.74-0.2281.23
    Capital Expenditures-8.17-1.65-2.37-2.87-4.31
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.003-0.0180.0660.541-5.49
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-8.17-1.67-2.3-2.33-9.8
    Financing Cash Flow Items—-2.08-0.011-0.0080.096
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities5.630.4-2.06-2.2-0.825
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-4.0724.5-9.11-4.78-9.4